slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 64,021-64,050
Pages 2,605
Rows per page 30
Component
64,021-64,050 of 78,138
11
The chart illustrates the mechanism of action and efficacy of NXC-201 (formerly HBI0101) in treating AL Amyloidosis.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Hypothesis Test1 hit
13
The slide uses a dual-metric comparison (Hematologic Response vs. Cardiac Response) to highlight NXC-201's efficacy.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Hypothesis Test1 hit
14
The slide uses a table structure to contrast treatment efficacy and patient outcomes, with a bar chart at the bottom illustrating patient population growth.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Hypothesis Test1 hit
15
The slide uses a visual comparison to highlight a 67% improvement in response rates for NXC-201 compared to competitors.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Hypothesis Test1 hit
17
Includes detailed clinical trial references in the footer.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · VisualizationLoop · Why Now1 hit
21
Includes a comparative table of clinical outcomes (ORR/CR/sCR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · VisualizationLoop · Why Now1 hit
22
The slide uses a wave-like visual to represent market size, with specific dollar amounts associated with different disease categories.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · VisualizationLoop · Why Now1 hit
25
The chart uses a grouped bar structure to compare NXC-201 (green) against other therapies (blue/red/grey).Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
28
The chart demonstrates deepening clinical responses over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
39
The slide uses a bubble chart to map clinical trials and a table to summarize drug performance metrics, highlighting low efficacy and high toxicity.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
40
The slide uses a combination of a conceptual chart and a data table to highlight efficacy and safety in a small sample size (n=4).Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
56
The slide uses a bar chart to contrast the combined annual sales of two sets of oncology drugs.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
57
The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
21
Includes a table of liquidity sources and a grouped bar chart showing liquidity coverage ratios over time.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
07
The chart illustrates a net increase of 148 MDs over the period.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations Beat · Key TakeawaysLoop · Logic Chain1 hit
13
The slide highlights a 162% growth in management fee revenue alongside strategic capital recycling.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations Beat · KPI Overview1 hit
21
The slide uses a timeline-like arrow to show the jump from #10 to #6, supported by four press clippings.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
25
The slide uses a stepped bar chart visual to represent strategic pillars.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
29
The chart displays annual growth in total capital returned, with a breakdown of components in the legend.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
31
The chart illustrates capital management strategy through share buybacks.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
32
Jefferies Financial Group | Investor Presentation Deck | 74 slidesJefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
33
The slide uses a donut chart to visualize the composition of non-compensation expenses.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
38
The slide highlights a divergence between company revenue growth and broader market fee pool contraction.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
44
Jefferies Financial Group | Investor Presentation Deck | 74 slidesJefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
45
The slide uses a bar chart to show growth and a list to show rankings.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
47
The chart highlights Jefferies' performance relative to competitors, emphasizing a positive 38.1% growth compared to mostly negative or lower growth among peers.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
49
The slide uses a visual representation of TAM expansion (Current vs. Expanded) to support the second strategic pillar.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
58
The slide uses a grouped bar chart to show growth across three fee categories.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
08
The slide uses a waterfall-style comparison to show the delta between ASMs and Revenue for 3Q23 and 4Q23.jetBlue | Results Presentation Deck | 20 slides · jetBlue
Conference presentation Investor relations Beat · Satisfaction1 hit
10
CASM = Cost per Available Seat Mile. The slide highlights the tension between internal cost-saving programs and external operational disruptions.jetBlue | Results Presentation Deck | 20 slides · jetBlue
Conference presentation Investor relations Beat · Satisfaction1 hit